Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02606461 |
Title | KCP-330-020 SEAL (Selinexor in Advanced Liposarcoma) (SEAL) |
Acronym | SEAL |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Karyopharm Therapeutics, Inc |
Indications | |
Therapies | |
Age Groups: | child | adult |
Covered Countries | USA | SWE | ITA | ISR | GBR | FRA | ESP | DEU | CAN | BEL |